HER2-positive breast cancer treatments and survival

Treatment for HER2-positive breast cancer often involves combinations of drugs and chemotherapy. Learn more about the different options and outcomes here.

Trastuzumab Deruxtecan for Metastatic HER2-Low Breast Cancer - NCI

Optimizing treatment for HER2-positive HR-positive breast cancer

Overall Survival Benefit from Trastuzumab-Based Treatment in HER2

Advancing Care and Improving Survival for Patients With HER2

Enhertu Effective in HER2-Positive Metastatic Breast Cancer - NCI

Breast Cancer Subtypes And Prognosis

Current treatment options for HER2-positive breast cancer patients

Year in Review: HER2-Positive Breast Cancer

Neratinib Improves Disease-Free Survival in Early-Stage HER2

How we treat patients with metastatic HER2-positive breast cancer

Neratinib Approved by FDA for HER2-Positive Breast Cancer - NCI

US Treatment Patterns for Young Women with HR-Positive, HER2

Long-term treatment patterns and survival in metastatic breast